与人类肝脏中CYP2D6表达和活性相关的新型独立转基因和Cis基因变异
Dylan Smith1, Bing He1, Jian Shi1
1Department of Pharmaceutical Sciences, Northeast Ohio Medical University, Rootstown, Ohio (D.S., X.W.); Department of Clinical Pharmacy, University of Michigan, Ann Arbor, Michigan (H.-J.Z.); Department of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, Michigan (B.H.); and Bristol Myers Squibb, Lawrence Township, New Jersey (J.S.).
研究人员确定了影响细胞染色体P450 2D6 (CYP2D6) 表达和活性的人类肝脏的新型遗传变异. 这些发现有助于解释药物代谢和对CYP2D6基质药物反应的个体间变异性.
科学领域:
- 药物基因组学 药物基因组学
- 药物新陈代谢 药物新陈代谢
- 人类遗传学 人类遗传学
背景情况:
- 细胞染色体P450 2D6 (CYP2D6) 是一种关键的酶,可以代谢20-25%的常见药物.
- 高CYP2D6基因多态性导致药物反应的显著个体间变异.
- 现有的知识让CYP2D6表达和活性变化的一部分无法解释.
研究的目的:
- 通过全基因组关联研究 (GWAS) 识别与人类肝脏中CYP2D6蛋白表达相关的新型遗传变异.
- 为了研究这些变体对肝脏CYP2D6活性的影响.
- 识别控制CYP2D6的独立的cis和trans作用变体,超出已知的功能性等位基因.
主要方法:
- 使用Illumina多民族基因型阵列 (MEGA) 进行全基因组关联研究 (GWAS).
- 通过数据独立获取 (DIA) 蛋白质学量化CYP2D6蛋白度.
- 测量CYP2D6活性通过甲O-脱甲基化试验在肝脏部分.
主要成果:
- GWAS确定了44个与CYP2D6蛋白表达相关的单核酸多态 (SNPs).
- 条件分析显示,五个独立的SNP (rs1807493,rs1062753,rs4073010,rs729559,rs80274432) 与CYP2D6蛋白水平有显著的相关性.
- 其中四个SNP (不包括rs80274432) 也与CYP2D6活性有显著的关联,表明新的cis-和trans-acting调节变异 (pQTLs/aQTLs).
结论:
- 确定了四种影响CYP2D6表达和活性的新型cis-和trans-acting遗传变异 (pQTLs/aQTLs),独立于已知的功能CYP2D6星基因.
- 这些发现提高了对CYP2D6变异性遗传基础的理解.
- 该研究提供了对治疗对CYP2D6基质药物反应的个体间差异的潜在见解.
相关概念视频
Cell Specific Gene Expression
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Single Nucleotide Polymorphisms-SNPs
Hepatic Drug Clearance: Role of Transporters
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...


